Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia
1 other identifier
interventional
130
1 country
19
Brief Summary
The aim of the study is to investigate whether intensive speech-language therapy (SLT) combined with anodal transcranial direct current stimulation (tDCS) leads to better communication performance than SLT combined with placebo stimulation (using sham-tDCS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2019
Longer than P75 for not_applicable
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedStudy Start
First participant enrolled
December 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 4, 2026
ExpectedMay 16, 2025
May 1, 2025
6.2 years
April 16, 2019
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in communication ability, as assessed by the Amsterdam Nijmegen Everyday Language Test
Amsterdam Nijmegen Everyday Language Test (A-scale; parallel versions used in counterbalanced order across participants); cf. Blomert L, Kean ML, Koster C, et al. Amsterdam-Nijmegen Everyday Language Test-Construction, Reliability and Validity. Aphasiology 1994; 8: 381-407.
Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups
Secondary Outcomes (11)
Change in naming ability, as assessed based on personally relevant trained and untrained items, consistent with previous work (see description)
Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups
Change in (non-)verbal communication, as assessed by the Scenario Test
Before the 3-week treatment period; 6-month follow-up
Change in (non-)verbal communication, as assessed by the Communicative Effectiveness Index
Before the 3-week treatment period; immediately after the 3-week treatment period; 6- and 12-month follow ups
Change in attention and executive function, as assessed by the subscales Go/NoGo and Alertness from Test of Attentional Performance
Before the 3-week treatment period; 6-month follow up
Change in non-verbal episodic memory, as assessed by the Figure Recognition Task from Benton Visual Retention Test
Before the 3-week treatment period; 6-month follow up
- +6 more secondary outcomes
Study Arms (2)
Experimental group
EXPERIMENTALAnodal transcranial direct current stimulation (tDCS) combined with speech-language therapy (SLT, including naming therapy and communicative-pragmatic therapy)
Control group
SHAM COMPARATORPlacebo stimulation (using sham-tDCS) combined with SLT
Interventions
Two daily sessions of intensive SLT combined with tDCS of the left primary motor cortex (M1)
Eligibility Criteria
You may qualify if:
- left-hemisphere cortical or subcortical stroke with first-ever aphasic symptoms
- at least 6 months post-onset of stroke;
- aphasia, as determined by the Aachen Aphasia Test (AAT);
- moderate-to-severe word finding difficulties (maximum of 75% correct items on a computerized naming task at baseline);
- at least 1 correct reaction on the first part of the AAT subscale Token Test (ensuring basic comprehension skills);
- at least 1 point on the communicative task of the AAT subscale Spontaneous Speech (ensuring basic communication abilities);
- German as first language;
- intact left-hemisphere "hand knob" without right prefrontal lesions for placement of tDCS electrodes, as confirmed by magnetic resonance imaging or computer tomography scans.
You may not qualify if:
- contraindications for tDCS (e.g., cardiac pacemaker, history of seizures, implanted metal inside the head);
- more than one clinically apparent stroke with aphasic symptoms;
- other severe neurological diseases (e.g., brain tumor, and subdural hematoma);
- epilepsy with seizures during the last 12 months prior to study start and/or intake of sedating antiepileptic drugs (barbiturates and benzodiazepines),
- history of severe alcohol or drug abuse;
- current severe depression;
- current psychosis or other relevant psychiatric condition;
- very severe apraxia of speech, as revealed by Hierarchical Word Lists;
- severe non-verbal cognitive deficits, as indicated by the Corsi Block-Tapping Task;
- severe uncontrolled medical problems;
- severely impaired vision or hearing that prevents patients from engaging in intensive SLT;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (19)
Aphasiestation RWTH Aachen
Aachen, 52074, Germany
Kliniken Schmieder Allensbach
Allensbach, 78476, Germany
Schön Klinik Bad Aibling Harthausen
Bad Aibling, 83209, Germany
Wicker Klinik Bad Homburg
Bad Homburg, 61348, Germany
Moritz Kliniken Bad Klosterlausnitz
Bad Klosterlausnitz, 07639, Germany
Median Klinik Bad Sülze
Bad Sülze, 18334, Germany
ZAR Berlin
Berlin, 10115, Germany
Kliniken Schmieder Gailingen
Gailingen, 78262, Germany
Klinikum Christophsbad Göppingen
Göppingen, 73035, Germany
University Medicine Greifswald, Department of Neurology
Greifswald, 17475, Germany
BDH-Klinik Greifswald gGmbH
Greifswald, 17491, Germany
Kliniken Schmieder Heidelberg
Heidelberg, 69117, Germany
Hospital zum Heiligen Geist Kempen
Kempen, 47906, Germany
Tagesklinik MPI Leipzig
Leipzig, 04103, Germany
Logo Zentrum Lindlar
Lindlar, 51789, Germany
TheraVent aktiv Marbach
Marbach, 71672, Germany
St. Mauritius Therapieklinik
Meerbusch, 40670, Germany
EUFH Rostock
Rostock, 18057, Germany
Aphasie-Zentrum Vechta gGmbH
Vechta, 49377, Germany
Related Publications (2)
Unger N, Stahl B, Darkow R, Scholz V, Weinmar I, Schmidt J, Breitenstein C, Meinzer M, Grewe T, Floel A. [Transcranial direct current stimulation to enhance training effectiveness in chronic poststroke aphasia-A challenge for recruiting participants]. Nervenarzt. 2024 Apr;95(4):368-375. doi: 10.1007/s00115-023-01572-7. Epub 2024 Jan 4. German.
PMID: 38175228DERIVEDStahl B, Darkow R, von Podewils V, Meinzer M, Grittner U, Reinhold T, Grewe T, Breitenstein C, Floel A. Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia: A Randomized Controlled Trial Protocol. Front Neurol. 2019 Oct 22;10:1089. doi: 10.3389/fneur.2019.01089. eCollection 2019.
PMID: 31695667DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes Floeel, Prof.
University Medicine Greifswald
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2019
First Posted
April 29, 2019
Study Start
December 6, 2019
Primary Completion
February 4, 2026
Study Completion (Estimated)
August 4, 2026
Last Updated
May 16, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share